Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

Teva Pharmaceutical has announced a collaboration with Fosun Pharma to advance the global development of the ATTENUKINE ...

Sweeping changes made by RFK Jr at the CDC have weakened the US's immunisation programme, according to former ACIP members.

The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney ...

European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.

After Biogen failed with a takeover bid in January, Supernus has swooped in to buy the postpartum depression pill developer.

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.